Latest Insider Transactions at Boston Scientific Corp (BSX)
This section provides a real-time view of insider transactions for Boston Scientific Corp (BSX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BOSTON SCIENTIFIC CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BOSTON SCIENTIFIC CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 12
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Bona fide gift
|
Direct |
2,610
-6.57%
|
-
|
|
Nov 08
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Open market or private sale
|
Direct |
30,580
-43.51%
|
$2,660,460
$87.66 P/Share
|
|
Nov 08
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
17,362
+19.81%
|
$416,688
$24.55 P/Share
|
|
Nov 05
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
162,778
-4.84%
|
$13,673,352
$84.95 P/Share
|
|
Nov 05
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
111,887
+3.27%
|
$1,790,192
$16.79 P/Share
|
|
Nov 01
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
6,983
-17.9%
|
$586,572
$84.33 P/Share
|
|
Nov 01
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,263
+5.24%
|
$85,260
$20.91 P/Share
|
|
Oct 07
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
132,527
-45.23%
|
$11,264,795
$85.0 P/Share
|
|
Oct 07
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
116,639
+18.24%
|
$2,449,419
$21.12 P/Share
|
|
Oct 07
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
162,777
-4.81%
|
$13,673,268
$84.63 P/Share
|
|
Oct 07
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
111,886
+3.17%
|
$1,790,176
$16.79 P/Share
|
|
Oct 01
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
6,983
-16.73%
|
$579,589
$83.86 P/Share
|
|
Oct 01
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,263
+4.91%
|
$85,260
$20.91 P/Share
|
|
Sep 05
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
162,777
-9.12%
|
$13,184,937
$81.17 P/Share
|
|
Sep 05
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
111,886
+3.09%
|
$1,790,176
$16.79 P/Share
|
|
Sep 03
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
6,983
-15.71%
|
$565,623
$81.7 P/Share
|
|
Sep 03
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,263
+4.62%
|
$85,260
$20.91 P/Share
|
|
Aug 30
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Bona fide gift
|
Indirect |
176,245
-45.72%
|
-
|
|
Aug 30
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Bona fide gift
|
Indirect |
209,278
+24.0%
|
-
|
|
Aug 28
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Open market or private sale
|
Direct |
14,132
-7.42%
|
$1,130,560
$80.0 P/Share
|
|
Aug 26
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
14,012
-56.47%
|
$1,106,948
$79.25 P/Share
|
|
Aug 26
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
4,185
+7.84%
|
$79,515
$19.99 P/Share
|
|
Aug 06
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Discretionary transaction
|
Indirect |
10,843
+44.76%
|
$791,539
$73.76 P/Share
|
|
Aug 01
2024
|
David C Habiger Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,407
+37.26%
|
-
|
|
Aug 01
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
6,983
-14.8%
|
$516,742
$74.12 P/Share
|
|
Aug 01
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,263
+4.36%
|
$85,260
$20.91 P/Share
|
|
Jul 01
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
6,983
-14.0%
|
$537,691
$77.3 P/Share
|
|
Jul 01
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,263
+4.13%
|
$85,260
$20.91 P/Share
|
|
Jul 01
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,952
-5.37%
|
$148,352
$76.41 P/Share
|
|
Jul 01
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
4,036
+9.99%
|
-
|
|
Jun 03
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
6,983
-13.27%
|
$523,725
$75.33 P/Share
|
|
Jun 03
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,263
+3.93%
|
$85,260
$20.91 P/Share
|
|
May 29
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
63,802
-69.48%
|
$4,785,150
$75.1 P/Share
|
|
May 29
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
33,726
+26.86%
|
$573,342
$17.26 P/Share
|
|
May 28
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
14,011
-40.96%
|
$1,050,825
$75.34 P/Share
|
|
May 28
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
4,186
+5.8%
|
$79,534
$19.99 P/Share
|
|
May 23
2024
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
47,621
-17.54%
|
$3,571,575
$75.11 P/Share
|
|
May 22
2024
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
64,454
-19.18%
|
$4,834,050
$75.91 P/Share
|
|
May 22
2024
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
64,454
+4.93%
|
$1,353,534
$21.3 P/Share
|
|
May 22
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Open market or private sale
|
Direct |
15,006
-31.7%
|
$1,140,456
$76.01 P/Share
|
|
May 22
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
15,006
+24.07%
|
$405,162
$27.09 P/Share
|
|
May 21
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Open market or private sale
|
Direct |
18,037
-35.81%
|
$1,352,775
$75.6 P/Share
|
|
May 21
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
18,037
+26.37%
|
$432,888
$24.55 P/Share
|
|
May 13
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Bona fide gift
|
Direct |
2,380
-1.23%
|
-
|
|
May 10
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Open market or private sale
|
Direct |
12,931
-29.16%
|
$956,894
$74.14 P/Share
|
|
May 10
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
12,931
+22.57%
|
$206,896
$16.31 P/Share
|
|
May 09
2024
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+50.0%
|
-
|
|
May 09
2024
|
Yoshiaki Fujimori Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+50.0%
|
-
|
|
May 09
2024
|
Susan E Morano Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,871
+19.36%
|
-
|
|
May 09
2024
|
Edward J Ludwig Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,901
+6.15%
|
-
|